» Articles » PMID: 28028717

Multi-drug Resistant Uropathogenic Escherichia Coli and Its Treatment by Chinese Medicine

Overview
Date 2016 Dec 29
PMID 28028717
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To investigate the resistance and virulence profiles of uropathogenic Escherichia coli (UPEC) and its treatment by Chinese medicine (CM) Fuzheng Qingre Lishi Formula (, FQLF).

Methods: UPEC strains were isolated from recurrent urinary tract infections (UTIs) patients. Patient sensitivities to 17 antibiotics were tested by the disk diffusion method. Virulence genes were screened by plolymerase chain reaction. A mouse model was constructed using a multi-drug resistant and virulent UPEC strain and treated with FQLF or the antibiotic imipenem. The treatment efficacy was evaluated by bacterial clearance from urine and the urinary organs.

Results: A total of 90 UPEC strains were collected, and 94.4% of the isolates were resistant to at least 1 antibiotic. Approximately 66.7% of the UPEC strains were multi-drug resistant. More than one virulence gene was found in 85.6% of the isolates. The extended-spectrum β-lactamases (ESBL)-positive strains were more resistant than the negative ones. The virulence gene number was positively correlated with the resistance number (P<0.05). A mouse model was successfully constructed using UPEC10. Treatment with either FQLF or antibiotics significantly cleared bacteria from the mouse urine after 14 days. In the untreated control, the bacteria lasted for 28 days. FQLF treatment of the UTI mouse model greatly reduced the bacterial number in the kidney and bladder, but could not completely clear the bacteria.

Conclusions: Multi-drug resistance is common among UPEC isolates, and the resistance is positively related with virulence. FQLF could treat UPEC UTIs, but could not completely clear the bacteria from the host.

Citing Articles

Low Concentration of Wenyang Tonglin Decoction Promotes Conjugation and Transfer of Drug-Resistant Plasmids among Heterologous Strains.

Wang B, Bu H, Xia L, Jiang X, Tong Y Chin J Integr Med. 2024; 30(8):721-728.

PMID: 38816636 DOI: 10.1007/s11655-024-3904-4.


Uropathogenic infection: innate immune disorder, bladder damage, and Tailin Fang II.

Li Z, Li J, Li T, Song Z, Gong X Front Cell Infect Microbiol. 2024; 14:1322119.

PMID: 38638825 PMC: 11024302. DOI: 10.3389/fcimb.2024.1322119.


Modified Zhibai Dihuang pill alleviated urinary tract infection induced by extended-spectrum β-lactamase in rats by regulating biofilm formation.

Chen K, Zhu Y, Su H, Jiang H, Liu X Pharm Biol. 2023; 61(1):674-682.

PMID: 37096639 PMC: 10132235. DOI: 10.1080/13880209.2023.2199786.


Identification of potential matrix metalloproteinase-2 inhibitors from natural products through advanced machine learning-based cheminformatics approaches.

Yang R, Zhao G, Cheng B, Yan B Mol Divers. 2022; 27(3):1053-1066.

PMID: 35773549 DOI: 10.1007/s11030-022-10467-9.


YdiV regulates Escherichia coli ferric uptake by manipulating the DNA-binding ability of Fur in a SlyD-dependent manner.

Zhang F, Li B, Dong H, Chen M, Yao S, Li J Nucleic Acids Res. 2020; 48(17):9571-9588.

PMID: 32813023 PMC: 7515728. DOI: 10.1093/nar/gkaa696.


References
1.
Foxman B . The epidemiology of urinary tract infection. Nat Rev Urol. 2010; 7(12):653-60. DOI: 10.1038/nrurol.2010.190. View

2.
Hung C, Dodson K, Hultgren S . A murine model of urinary tract infection. Nat Protoc. 2009; 4(8):1230-43. PMC: 2963178. DOI: 10.1038/nprot.2009.116. View

3.
Johnson J, Stell A . Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J Infect Dis. 1999; 181(1):261-72. DOI: 10.1086/315217. View

4.
Asadi Karam M, Oloomi M, Mahdavi M, Habibi M, Bouzari S . Vaccination with recombinant FimH fused with flagellin enhances cellular and humoral immunity against urinary tract infection in mice. Vaccine. 2013; 31(8):1210-6. DOI: 10.1016/j.vaccine.2012.12.059. View

5.
Lu A, Jia H, Xiao C, Lu Q . Theory of traditional Chinese medicine and therapeutic method of diseases. World J Gastroenterol. 2004; 10(13):1854-6. PMC: 4572216. DOI: 10.3748/wjg.v10.i13.1854. View